Back to today’s briefing

Story perspectives

GLP-1 Drugs Show Promise for Cardiovascular and Kidney Health

3/29/2026

36 3 Full Breakdown

Summary

Story summary

GLP-1 drugs originally designed for type 2 diabetes may lower cardiovascular disease risk, improve sleep apnea, and aid in liver disease treatment.
They also show promise in reducing kidney disease progression and certain cancers.
Side effects include nausea, though long-term effects remain uncertain.
Experts urge consulting a doctor before starting GLP-1 therapy and emphasize the need for further research.

1 of 1

Story summary

GLP-1 drugs originally designed for type 2 diabetes may lower cardiovascular disease risk, improve sleep apnea, and aid in liver disease treatment.
They also show promise in reducing kidney disease progression and certain cancers.
Side effects include nausea, though long-term effects remain uncertain.
Experts urge consulting a doctor before starting GLP-1 therapy and emphasize the need for further research.